TrHCROSS - Joint injections (cross-linked HA 2%)

  • TrHCROSS - Joint injections (cross-linked HA 2%) 1
  • TrHCROSS - Joint injections (cross-linked HA 2%) 2
Product Description

TrHCROSS 2% is a biocompatible hydrogel of cross-linked sodium hyaluronate obtained by biofermentation. This is a single injection, designed to relieve joint pain in osteoarthritis by replacing natural joint fluid and replenishing lubricating and shock-absorbing functions.

Properties
+ Reduces the pain and increases the functionality of the joint.
+ Lubricating and shock-absorption effect.
+ Improves mobility and quality of life of the patient.
Packaging
TrHCROSS is supplied in a pre-filled Type I syringe of 4,4 mL, ready to use. It is presented in an individual blister along with four control labels and instructions for use.

Read more Show less

i+Med S. Coop.

  • ES
  • 2018
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
CMO/CDMO
Contract Service
Distributor/Import Export
Manufacturer/Innovator
OTC
Pharmaceutical company
Veterinary Company
Primary activities
Contract Manufacturer
Medical Devices
OTC
Out-licensing specialist
Pharmaceutical Company (innovator finished products)
View company profile
Categories
more categories Show less
Specifications
  • CAS Registry Number
    9004-61-9
  • Details
    TrHCROSS 2.0%

    One shot injecatble cross-linked hyaluronic acid viscosupplementation of synovial fluid when its viscosity has been reduced due to knee osteoarthritis (KOA) process.+ Reduces the pain and increases the functionality of the affected joint.+ Provides a lubricant and shock-absortion effect on the affected joint.+ Improves the quality of life of the patient

  • Selling Points
    Bone & Joint Health; International Approvals/Standards; Product Features; GENERAL INFORMATION

    + European product: All the ingredients we use are 100% European origin, and the products are entirely manufactured at our facilities in the north of Spain.

    + MDR certificate: The submission, clinical trials and documentation required to obtain the MDR certificate have been submitted and we expect to receive it in 2024.

    + Wide range: We offer viscosupplements of different strengths so doctors can choose what best adjusts to their needs and mode of work.

    + Hyaluronic Acid specialization: We have been working with this complex polymer for 10 years. We not only add HA to our products, but we master it to explode its potential and obtain high-added value injectables.

    + Formulations: We carefully selected our HA’s molecular weight and polymer chain length to make it optimal for its purpose.

    + Non-animal origin HA

    + SARE Technology®:&nb...
  • Supplied from
    Spain
More specifications Fewer specifications
Sales Markets
Show more Show less

i+Med S. Coop.

  • ES
  • 2018
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
CMO/CDMO
Contract Service
Distributor/Import Export
Manufacturer/Innovator
OTC
Pharmaceutical company
Veterinary Company
Primary activities
Contract Manufacturer
Medical Devices
OTC
Out-licensing specialist
Pharmaceutical Company (innovator finished products)
View company profile

More Products from i+Med S. Coop. (10)

  • BtHLINE and BtHCROSS - Dermal fillers for aestheic medicine (Linear HA 1,4%, Crosslinked HA 1,5%, 1,75%, 2%)

    Product BtHLINE and BtHCROSS - Dermal fillers for aestheic medicine (Linear HA 1,4%, Crosslinked HA 1,5%, 1,75%, 2%)

    BtHLINE 1,4% is a biocompatible linear hyaluronic acid hydrogel intended as a dermatologicaltreatment for aesthetic purposes. Administered by intradermal injection.

    Composition
    Non-animal HA Low level of endotoxins
    Properties
    BtHLINE 1,4% + Restores aged skin structures. ...
  • Daydrop - controlled release multidose eye drops with ectoine for dry eye

    Product Daydrop - controlled release multidose eye drops with ectoine for dry eye

    DayDrop is an eye drop indicated to relieve dryness and eye irritation caused by environmental factors (wind, dust, smoke, air conditioning, dry heat), prolonged use of screens or contact lenses and / or certain ocular pathologies that occur with these symptoms.
    Hydrates, lubricates and protects for...
  • DayDrop - eye drops with 12h sustained-release system of ectoine

    Product DayDrop - eye drops with 12h sustained-release system of ectoine

    DAYDROP. INNOVATIVE FORMULA WITH HIALURONIC ACID AND 12h SUSTAINED RELEASE OF ECTOINE Eye drops indicated to relieve dryness and eye irritation caused by environmental factors (wind, dust, smoke, air conditioning, dry heat), prolonged use of screens or contact lenses and / or certain ocular pathologies th...
  • ADAPTEK® TECHNOLOGY

    Product ADAPTEK® TECHNOLOGY

    ADAPTEK® TECHNOLOGY is the general name for our 4 international patents and expertise in nanotechnology and controlled release systems.This is a transversal technology that allows to develop customized biopolymeric nanohydrogels, allowing the load with different API (drugs, vitamins, growth factors, etc.)....
  • OpHLINE - Ophthalmic Viscosurgical Devices (HA 1,4%/2%/3%)

    Product OpHLINE - Ophthalmic Viscosurgical Devices (HA 1,4%/2%/3%)

    OpHLINE is an ophthalmic viscosurgical devise (OVD) indicated as a coadjuvant during surgical procedures, involving the anterior chamber of the eye, especially in cataract surgery, including the extraction of the lens and the insertion of intraocular lenses.
    OpHLINE is available in 3 models ...
  • BtHCROSS - Dermal filler (cross-linked HA 1,5%/1,75%/2%)

    Product BtHCROSS - Dermal filler (cross-linked HA 1,5%/1,75%/2%)

    BtHCROSS is a biocompatible cross-linked hyaluronic acid hydrogel intended as a dermatological treatment for aesthetic purposes. It is administered by intradermal injection and designed to restore and correct facial volumes and fill wrinkles and folds.
    Depending on the depth of the wrinkles an...
  • DayDrop - eye drops with the sustained-release system of ectoine

    Product DayDrop - eye drops with the sustained-release system of ectoine

    DayDrop is an ophthalmic solution with sustained release of ectoine, indicated to alleviate the ocular dryness and irritation produced by environmental factors (wind, dust, air conditioning, dry heat), prolonged use of screens or contact lenses and some pathologies that present the above mentioned symp...
  • Profilm COLD SORES - protective film for cold sores(herpes)

    Product Profilm COLD SORES - protective film for cold sores(herpes)

    Profilm COLD SORES is a liquid dressing for topical use, indicated to relieve the initial symptoms of cold sores. Its technology firms a protective and discreet physical barrier that adapts to the shape of the skin, reducing the risk of infection and the spread of the virus. Due to its composi...
  • Profilm MOUTH ULCERS - protective film for mouth ulcers and aphthae

    Product Profilm MOUTH ULCERS - protective film for mouth ulcers and aphthae

    Profilm MOUTH ULCERS is a hydrogel, supplemented with natural extracts of propolis and tea tree, and enriched with stabilized vitamin C. After its application, and thanks to its technology, a protective physical barrier is formed which adapts to the shape of the mucosa, preventing contact with...
  • BuddyDrops - eye drops with ectoine and HA for veterinary use

    Product BuddyDrops - eye drops with ectoine and HA for veterinary use

    BuddyDrops is a sterile moisturizing and lubricating long-lasting ophthalmic solution intended for veterinary use. BuddyDrops increases the contact time of the drop on the ocular surface reducing the need for repeated applications of the product and thus improving therapeutic compliance.

    ...

i+Med S. Coop. resources (1)

  • i+Med Company profile

    Brochure i+Med Company profile

    i+Med is a biotech company formed by highly qualified personnel, focused on the R&D and manufacture of new products for third parties. Our ADAPTEK® TECHNOLOGY enables the development of customized biopolymeric nanohydrogels, allowing the load with different API (drugs, vitamins, growth factors, etc.). These intelligent nanoparticles could be programmed to respond to external stimulus (E.g. pH or t˚) that allow the controlled release of APIs. As a result, we can develop high added value and differentiated products that provide our customers with a key competitive advantage in t...